IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,194,139 | -50.5% | 26,974 | -54.1% | 0.03% | -46.9% |
| Q2 2023 | $2,410,512 | +11.9% | 58,750 | -2.5% | 0.05% | +8.9% |
| Q1 2023 | $2,153,728 | +309.5% | 60,261 | +414.6% | 0.04% | +350.0% |
| Q1 2021 | $526,000 | +20.9% | 11,710 | +52.4% | 0.01% | +25.0% |
| Q4 2020 | $435,000 | -24.9% | 7,685 | -37.0% | 0.01% | -38.5% |
| Q3 2020 | $579,000 | -30.0% | 12,206 | -12.9% | 0.01% | -31.6% |
| Q2 2020 | $827,000 | -11.3% | 14,019 | -28.9% | 0.02% | -29.6% |
| Q1 2020 | $932,000 | -31.5% | 19,718 | -12.4% | 0.03% | -12.9% |
| Q4 2019 | $1,360,000 | -10.5% | 22,499 | -11.3% | 0.03% | -16.2% |
| Q3 2019 | $1,519,000 | – | 25,363 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |